KQ-2003 CAR-T Cell Therapy

· Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KQ-2003 CAR-T Cell Therapy, covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome [Phase 1]